378 related articles for article (PubMed ID: 20949621)
1. Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders.
Gremer L; Merbitz-Zahradnik T; Dvorsky R; Cirstea IC; Kratz CP; Zenker M; Wittinghofer A; Ahmadian MR
Hum Mutat; 2011 Jan; 32(1):33-43. PubMed ID: 20949621
[TBL] [Abstract][Full Text] [Related]
2. Diverging gain-of-function mechanisms of two novel KRAS mutations associated with Noonan and cardio-facio-cutaneous syndromes.
Cirstea IC; Gremer L; Dvorsky R; Zhang SC; Piekorz RP; Zenker M; Ahmadian MR
Hum Mol Genet; 2013 Jan; 22(2):262-70. PubMed ID: 23059812
[TBL] [Abstract][Full Text] [Related]
3. Two novel germline KRAS mutations: expanding the molecular and clinical phenotype.
Stark Z; Gillessen-Kaesbach G; Ryan MM; Cirstea IC; Gremer L; Ahmadian MR; Savarirayan R; Zenker M
Clin Genet; 2012 Jun; 81(6):590-4. PubMed ID: 21797849
[TBL] [Abstract][Full Text] [Related]
4. Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes.
Kratz CP; Franke L; Peters H; Kohlschmidt N; Kazmierczak B; Finckh U; Bier A; Eichhorn B; Blank C; Kraus C; Kohlhase J; Pauli S; Wildhardt G; Kutsche K; Auber B; Christmann A; Bachmann N; Mitter D; Cremer FW; Mayer K; Daumer-Haas C; Nevinny-Stickel-Hinzpeter C; Oeffner F; Schlüter G; Gencik M; Überlacker B; Lissewski C; Schanze I; Greene MH; Spix C; Zenker M
Br J Cancer; 2015 Apr; 112(8):1392-7. PubMed ID: 25742478
[TBL] [Abstract][Full Text] [Related]
5. Craniosynostosis in patients with RASopathies: Accumulating clinical evidence for expanding the phenotype.
Ueda K; Yaoita M; Niihori T; Aoki Y; Okamoto N
Am J Med Genet A; 2017 Sep; 173(9):2346-2352. PubMed ID: 28650561
[TBL] [Abstract][Full Text] [Related]
6. Autism traits in the RASopathies.
Adviento B; Corbin IL; Widjaja F; Desachy G; Enrique N; Rosser T; Risi S; Marco EJ; Hendren RL; Bearden CE; Rauen KA; Weiss LA
J Med Genet; 2014 Jan; 51(1):10-20. PubMed ID: 24101678
[TBL] [Abstract][Full Text] [Related]
7. De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features.
Søvik O; Schubbert S; Houge G; Steine SJ; Norgård G; Engelsen B; Njølstad PR; Shannon K; Molven A
J Med Genet; 2007 Jul; 44(7):e84. PubMed ID: 17601930
[TBL] [Abstract][Full Text] [Related]
8. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
Tidyman WE; Rauen KA
Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
[TBL] [Abstract][Full Text] [Related]
9. [Cardiofaciocutaneous syndrome, a Noonan syndrome related disorder: clinical and molecular findings in 11 patients].
Carcavilla A; García-Miñaúr S; Pérez-Aytés A; Vendrell T; Pinto I; Guillén-Navarro E; González-Meneses A; Aoki Y; Grinberg D; Ezquieta B
Med Clin (Barc); 2015 Jan; 144(2):67-72. PubMed ID: 25194980
[TBL] [Abstract][Full Text] [Related]
10. Costello syndrome and related disorders.
Quezada E; Gripp KW
Curr Opin Pediatr; 2007 Dec; 19(6):636-44. PubMed ID: 18025929
[TBL] [Abstract][Full Text] [Related]
11. Cardiac manifestations and gene mutations of patients with RASopathies in Taiwan.
Lee CL; Tan LTH; Lin HY; Hwu WL; Lee NC; Chien YH; Chuang CK; Wu MH; Wang JK; Chu SY; Lin JL; Lo FS; Su PH; Hsu CC; Ko YY; Chen MR; Chiu HC; Lin SP
Am J Med Genet A; 2020 Feb; 182(2):357-364. PubMed ID: 31837205
[TBL] [Abstract][Full Text] [Related]
12. Objective studies of the face of Noonan, Cardio-facio-cutaneous, and Costello syndromes: A comparison of three disorders of the Ras/MAPK signaling pathway.
Allanson JE
Am J Med Genet A; 2016 Oct; 170(10):2570-7. PubMed ID: 27155212
[TBL] [Abstract][Full Text] [Related]
13. Noonan syndrome caused by germline KRAS mutation in Taiwan: report of two patients and a review of the literature.
Lo FS; Lin JL; Kuo MT; Chiu PC; Shu SG; Chao MC; Lee YJ; Lin SP
Eur J Pediatr; 2009 Aug; 168(8):919-23. PubMed ID: 18958496
[TBL] [Abstract][Full Text] [Related]
14. NRAS associated RASopathy and embryonal rhabdomyosarcoma.
Garren B; Stephan M; Hogue JS
Am J Med Genet A; 2020 Jan; 182(1):195-200. PubMed ID: 31697451
[TBL] [Abstract][Full Text] [Related]
15. Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders.
Kratz CP; Schubbert S; Bollag G; Niemeyer CM; Shannon KM; Zenker M
Cell Cycle; 2006 Aug; 5(15):1607-11. PubMed ID: 16921267
[TBL] [Abstract][Full Text] [Related]
16. Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes.
Kratz CP; Rapisuwon S; Reed H; Hasle H; Rosenberg PS
Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):83-9. PubMed ID: 21500339
[TBL] [Abstract][Full Text] [Related]
17. Epilepsy in RAS/MAPK syndrome: two cases of cardio-facio-cutaneous syndrome with epileptic encephalopathy and a literature review.
Adachi M; Abe Y; Aoki Y; Matsubara Y
Seizure; 2012 Jan; 21(1):55-60. PubMed ID: 21871821
[TBL] [Abstract][Full Text] [Related]
18. The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of selected syndromes.
Bezniakow N; Gos M; Obersztyn E
Dev Period Med; 2014; 18(3):285-96. PubMed ID: 25182392
[TBL] [Abstract][Full Text] [Related]
19. Neurodevelopmental Aspects of RASopathies.
Kim YE; Baek ST
Mol Cells; 2019 Jun; 42(6):441-447. PubMed ID: 31250618
[No Abstract] [Full Text] [Related]
20. Familial cardio-facio-cutaneous syndrome: Vertical transmission of the BRAF p.G464R pathogenic variant and review of the literature.
Rauen KA; Maeda Y; Egense A; Tidyman WE
Am J Med Genet A; 2021 Feb; 185(2):469-475. PubMed ID: 33274568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]